- Report
- March 2024
- 184 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- April 2024
- 282 Pages
Global
From €5293EUR$5,450USD£4,566GBP
- Report
- October 2023
- 140 Pages
Global
From €2427EUR$2,499USD£2,094GBP
- Report
- February 2024
- 139 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Drug Pipelines
- April 2024
- 200 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- January 2024
- 145 Pages
Global
From €4128EUR$4,250USD£3,561GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- October 2023
- 698 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- January 2024
- 250 Pages
Global
From €2380EUR$2,450USD£2,053GBP
- Report
- January 2024
- 348 Pages
Global
From €5219EUR$5,561USD£4,350GBP
- Report
- November 2023
- 30 Pages
Global
From €2671EUR$2,750USD£2,304GBP
- Report
- September 2023
- 170 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- March 2024
- 200 Pages
Global
From €4031EUR$4,150USD£3,477GBP
- Report
- May 2022
- 150 Pages
Global
From €2331EUR$2,400USD£2,011GBP
- Report
- October 2021
- 72 Pages
Global
From €777EUR$800USD£670GBP
- Report
- January 2023
- 160 Pages
Global
From €2418EUR$2,490USD£2,086GBP
- Report
- December 2019
- 139 Pages
United States
From €2914EUR$3,000USD£2,514GBP
- Report
- August 2018
- 15 Pages
Global
- Report
- January 2022
- 111 Pages
Global
From €4614EUR$4,750USD£3,980GBP
The Cystic Fibrosis Drug market is a subset of the larger Respiratory Drug market. It is composed of treatments and therapies designed to address the symptoms of cystic fibrosis, a genetic disorder that affects the lungs and digestive system. These drugs are used to reduce the amount of mucus in the lungs, improve breathing, and reduce the risk of infection. They may also be used to treat other symptoms, such as malnutrition, dehydration, and vitamin deficiencies.
The Cystic Fibrosis Drug market is highly competitive, with many companies developing and marketing treatments. Some of the major players in the market include Vertex Pharmaceuticals, Gilead Sciences, Novartis, and GlaxoSmithKline. Other companies, such as AbbVie, Merck, and Pfizer, are also active in the market. Show Less Read more